Souffle Therapeutics – DayRise Program Logo

Creating a program logo and design system for Souffle Therapeutics first ever clinical program to study, and measures of the efficacy of a new investigational siRNA therapy in a rare disease called Facioscapulohumeral muscular dystrophy (FSHD). Importantly this study will be the first clinical test of Soufflé’s scientific platform technology and the central hypothesis that it can deliver and internalize genetic medicines into specific cell types with precision to impact disease.

Logo and Design System
Credit: Waterhouse Brands
Lead Designer: Mark Guthridge